May 6, 2021|
In this recording of our latest webinar, our attorneys Jonathan Svitak, Rhonda Lorenz-Pignato, and Patrick Anderson offer exclusive insight into the Vaccine Injury Compensation Program (VICP).
Jonathan starts off by discussing the current status of the SIRVA removal issue and the future of Covid-19 vaccines and the Vaccine Injury Compensation Program. Next, Pat Anderson explains how a vaccine injury claim is processed in the VICP, from the date it’s filed all the way through resolution.
Lastly, Rhonda gives a brief overview of how the Vaccine Injury Table works along with a historical perspective of the value of SIRVA cases.
This webinar was originally filmed on April 16, 2021, at 10:00 a.m. CST.
Watch this full webinar now.
Schedule Your Free Consultation Today
Recent Blog Posts
How to File an HPV Vaccine Lawsuit in the VICP
By Katelyn Pater |
In most cases, getting an HPV vaccine is a walk in the park. Millions of preteens, teenagers, and young adults have been vaccinated against the human papillomavirus. Overall, HPV vaccines are very safe, according to the Centers for Disease Control (CDC). The benefits of HPV vaccination outweigh the potential adverse reactions. Many people have mild…
Tetanus Shot Side Effects in Adults: What You Need to Know
By Katelyn Pater |
According to the CDC, adults should receive the tetanus vaccine every 10 years. This vaccine helps prevent infection of tetanus bacteria, which is everywhere in the environment. But sometimes, people don’t get a tetanus shot booster until they’ve stepped on a rusty nail or were bitten by a dog. Needless to say, a lot of…
Arm Sore After a Meningitis Vaccine? You May Have SIRVA
By Katelyn Pater |
The meningitis vaccine, also known as meningococcal B vaccination, is recommended for preteens and teens. This age group is at an increased risk for meningococcal disease, which is a rare but serious illness. Preteens will typically receive one dose before high school. Teens and young adults entering college may receive a booster meningitis vaccine as…